FindDrugs.org

Fridays Review

Brand-level review · Last reviewed Sep 14, 2026

6.31/10

Operator-trust score

The brand-level factors every category shares — legitimacy, clinical oversight, transparency, privacy, policy, support — not price or per-treatment value.

Clinician accessInsurance-friendlyCash-pay

Our verdict

Fridays is a Miami-based telehealth membership that bundles compounded GLP-1 medication with unlimited provider visits, dietitian, mental-health and fitness coaching for one flat monthly fee. Its operator-trust score is 6.31 — the brand-level factors every category shares, not price or per-treatment value. It scores well on publishing all-inclusive pricing on its own site and on naming its state-regulated 503A compounding partners and its clinical network. It is held back by prescribing clinicians it does not name, eligibility criteria it does not publish, a BBB F rating for unanswered complaints, and shipping terms that appear nowhere on its pricing page or FAQ.

Fridays plans & reviews by category

Each category is scored separately. Read the full review where one exists — or check current pricing directly.

  • Semaglutide · injection$249/mo
  • Tirzepatide · injection$359/mo
  • Semaglutide · microdose$249/mo

Prices as of Sep 14, 2026 — verify current on the brand's site.

Key takeaways

  • Publishes fully worked, all-inclusive flat-fee pricing on its own site, with no separate membership, signup or lab charges.
  • Names its state-regulated 503A compounding-pharmacy partners with their cities and a testing regime — disclosure most of this category does not make.
  • Clinical oversight runs through OpenLoop with a medical intake and monitoring, but no individual prescribing clinician is named.
  • Publishes no shipping method, packaging or delivery timeframe on its pricing page or FAQ, so speed of access is undisclosed rather than established as slow.
  • Policies are clearly published but consumer-unfriendly: limited refunds, auto-renewal and no pause.
  • BBB complaints cite shipping delays, dosing errors and billing for unshipped product, and the profile carries an F rating for failing to respond to 9 of 11 of them.
  • Its accreditation could not be established either way — the certification registry returns HTTP 403 to us — so that factor is disclosed as unresolved rather than counted against it.

What is Fridays?

Fridays (joinfridays.com) is a Miami-based telehealth membership focused on weight management, founded around 2023. It does not employ the clinicians who prescribe: clinical services are delivered through OpenLoop Healthcare Partners, a white-label clinician network, and its medications are made by state-regulated 503A compounding partners that Fridays names publicly. The model is holistic rather than prescription-only, pairing obesity-medicine physicians, dietitians and mental-health counselors with nutrition, fitness and lifestyle coaching. It operates in one category, weight management, is available in 49 states — not Louisiana — and its compounded medications are made in FDA-registered facilities but are not individually FDA-approved.

Is Fridays legit?

Largely yes, with named intermediaries rather than named people. Fridays runs a real operation whose clinical and pharmacy chain flows through OpenLoop and through state-regulated 503A compounding partners it names, and it was not among the firms named in the September 2025 FDA action. What it does not do is name the individual clinicians who prescribe or publish the criteria they screen against, and its BBB profile carries complaints about dosing and shipping.

  • Licensed & accredited: Its clinical network runs through OpenLoop; we could not verify its accreditation status; Fridays was not named in the Sept-2025 FDA compounder wave — OpenLoop, Jul 2026.
  • Clinician model: Board-certified physician/NP oversight via OpenLoop with a medical intake and monitoring, though individual clinicians are not named — BBB profile, Jul 2026.
  • Medication & pharmacy: Publicly names its state-regulated 503A compounding-pharmacy partners with cities and a testing regime; per-pharmacy 503A/outsourcing-facility classification is not individually confirmed — Fridays (joinfridays.com), Jul 2026.
  • Watch-outs: BBB complaints cite dosing errors and shipping delays, and eligibility criteria and prescriber names are not published — BBB profile, Jul 2026.

Treatment options

What Fridays actually treats. Pricing lives in the plans table above and in each category review.

  • Weight loss (GLP-1)

    compounded semaglutide and tirzepatide by injection, plus a semaglutide microdosing option

Pros & cons

Pros

  • All-inclusive flat monthly fee with no hidden membership, signup or lab charges
  • Publicly names its partner compounding pharmacies and clinical network (OpenLoop)
  • Strong, recent, high-volume Trustpilot sentiment (4.5/5 across ~4,470 reviews)
  • Microdosing/low-start titration option
  • Comprehensive care: unlimited visits, dietitian, mental-health and fitness coaching

Cons

  • No individually named prescribing clinicians published on site
  • Contraindications and age criteria not published; eligibility floor as low as BMI 25
  • Refunds heavily restricted; no subscription pause; auto-renewal
  • BBB F rating with failure to respond to 9 of 11 complaints
  • Compounded meds are not FDA-approved; not available in Louisiana

The bottom line

Fridays suits members who want the whole programme in one predictable monthly price and who value the coaching as much as the prescription. Members who need to know who is prescribing, what the eligibility criteria are, or when a shipment will arrive will find none of those published, and the refund terms are restrictive enough to read before enrolling.

What changed & why

This brand's own history — every re-review and methodology recompute, logged. Rankings change when the evidence or the rules change, never for payment. See the site-wide methodology ledger for version history.

  1. Sep 18, 2026Initial score6.31

    Fridays' Operator Trust Score first recorded at 6.31 out of 10 — the earliest score in this log.

Review score changes

The timeline above is this brand's Operator Trust Score. Each review below is scored separately, and keeps its own history.

  • Weight Management / GLP-1 review— last changed Sep 14, 2026See changes

Work at Fridays?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Completeness was not recorded for this score · 9 sources cited

Regulatory

Reviews

Other

What we couldn't verify

  • CMO 'Dr. Moe Mossa' could not be confirmed; PR names founders Sina Arham and Dr. Weiss Surkhabi.
  • Individual prescribing clinicians not named on the site.
  • Full contraindication list and minimum age not published.
  • Per-pharmacy 503A vs 503B classification not individually confirmed.
  • Withdrawn — OpenLoop's LegitScript certification. OpenLoop's LegitScript certification is WITHDRAWN as a verified fact. The citation was OpenLoop's own newsroom announcing its own certification — the company is not the ORIGINATOR of a certification decision (LegitScript is) and is not INDEPENDENT of it. Treated the same way as Sprout Health's LegitScript claim, which this payload set already records as unverifiable.
  • Shipping and packaging detail (cold-chain packaging, injection supplies included) could not be verified: the third-party page carrying it returned HTTP 403, and neither joinfridays.com/pricing nor /faqs publishes shipping method or delivery times (both fetched 2026-08-10).
  • legitimacy-accreditation: re-encoded as a RETRIEVAL GAP (excluded, re-normalized out of the score) rather than brand opacity. The withdrawn claim was OpenLoop's LegitScript certification. LegitScript's public checker returns HTTP 403 to us (same reCAPTCHA gate that made Sprout's claim unverifiable), so this is retrieval failure, not brand non-disclosure. Scoring 62 instead of the original 76 would publish "we assessed Fridays' legitimacy and marked it down" when what happened is that we could not reach a certification registry. Re-normalized out.
  • Fridays' description of microdosing as "starting GLP-1 medications at lower doses to reduce side effects and improve tolerance" is not restated as a clinical statement: it is a general claim about dosing, sourced only to the brand's own FAQ, and a company page cannot carry one. What Fridays offers is reported; what microdosing does clinically is not. (2026-08-11)
  • Withdrawn — LegitScript. OpenLoop's LegitScript certification is not stated anywhere in this review. It was withdrawn to gaps[] on 2026-08-11 — the only source was OpenLoop's own announcement, which fails INDEPENDENT, and LegitScript's public checker returns HTTP 403 to us so the registry cannot be queried. Attributing the claim was not sufficient either: 'LegitScript-certified' is a regulatory term of art, and using it asserts a regulatory status we cannot back regardless of who we attribute it to. The term is therefore absent from the body, not merely hedged. (2026-08-11)
Last reviewed Sep 14, 2026View the ledger